These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27743558)

  • 1. Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma.
    Galli S; Naranjo A; Van Ryn C; Tilan JU; Trinh E; Yang C; Tsuei J; Hong SH; Wang H; Izycka-Swieszewska E; Lee YC; Rodriguez OC; Albanese C; Kitlinska J
    Am J Pathol; 2016 Nov; 186(11):3040-3053. PubMed ID: 27743558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance.
    Czarnecka M; Trinh E; Lu C; Kuan-Celarier A; Galli S; Hong SH; Tilan JU; Talisman N; Izycka-Swieszewska E; Tsuei J; Yang C; Martin S; Horton M; Christian D; Everhart L; Maheswaran I; Kitlinska J
    Oncogene; 2015 Jun; 34(24):3131-43. PubMed ID: 25132261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy.
    Lu C; Everhart L; Tilan J; Kuo L; Sun CC; Munivenkatappa RB; Jönsson-Rylander AC; Sun J; Kuan-Celarier A; Li L; Abe K; Zukowska Z; Toretsky JA; Kitlinska J
    Oncogene; 2010 Oct; 29(41):5630-42. PubMed ID: 20676138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y (NPY) in tumor growth and progression: Lessons learned from pediatric oncology.
    Tilan J; Kitlinska J
    Neuropeptides; 2016 Feb; 55():55-66. PubMed ID: 26549645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis.
    Medeiros PJ; Jackson DN
    Peptides; 2013 Oct; 48():106-13. PubMed ID: 23932937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide y and neuropeptide y y5 receptor interaction restores impaired growth potential of aging bone marrow stromal cells.
    Igura K; Haider HKh; Ahmed RP; Sheriff S; Ashraf M
    Rejuvenation Res; 2011 Aug; 14(4):393-403. PubMed ID: 21595512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y receptor interactions regulate its mitogenic activity.
    Czarnecka M; Lu C; Pons J; Maheswaran I; Ciborowski P; Zhang L; Cheema A; Kitlinska J
    Neuropeptides; 2019 Feb; 73():11-24. PubMed ID: 30503694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Y5 receptors mediate neuropeptide Y actions at excitatory synapses in area CA3 of the mouse hippocampus.
    Guo H; Castro PA; Palmiter RD; Baraban SC
    J Neurophysiol; 2002 Jan; 87(1):558-66. PubMed ID: 11784771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y stimulates proliferation and migration in the 4T1 breast cancer cell line.
    Medeiros PJ; Al-Khazraji BK; Novielli NM; Postovit LM; Chambers AF; Jackson DN
    Int J Cancer; 2012 Jul; 131(2):276-86. PubMed ID: 21823118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors.
    Kitlinska J; Abe K; Kuo L; Pons J; Yu M; Li L; Tilan J; Everhart L; Lee EW; Zukowska Z; Toretsky JA
    Cancer Res; 2005 Mar; 65(5):1719-28. PubMed ID: 15753367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y/Y5 Receptor Pathway Stimulates Neuroblastoma Cell Motility Through RhoA Activation.
    Abualsaud N; Caprio L; Galli S; Krawczyk E; Alamri L; Zhu S; Gallicano GI; Kitlinska J
    Front Cell Dev Biol; 2020; 8():627090. PubMed ID: 33681186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of neuropeptide Y, Y1 and Y2 receptors, but not Y5 receptor, within hippocampus and temporal lobe cortex of tremor rats.
    Xu X; Guo F; He Q; Cai X; Min D; Wang Q; Wang S; Tian L; Cai J; Zhao Y
    Neuropeptides; 2014 Apr; 48(2):97-105. PubMed ID: 24444822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of neuropeptide Y Y2 and Y5 receptor expression in the mouse hypothalamus.
    Fetissov SO; Byrne LC; Hassani H; Ernfors P; Hökfelt T
    J Comp Neurol; 2004 Mar; 470(3):256-65. PubMed ID: 14755515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line.
    Sheriff S; Ali M; Yahya A; Haider KH; Balasubramaniam A; Amlal H
    Mol Cancer Res; 2010 Apr; 8(4):604-14. PubMed ID: 20332211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies.
    Sánchez ML; Rodríguez FD; Coveñas R
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancer.
    Dietrich P; Wormser L; Fritz V; Seitz T; De Maria M; Schambony A; Kremer AE; Günther C; Itzel T; Thasler WE; Teufel A; Trebicka J; Hartmann A; Neurath MF; von Hörsten S; Bosserhoff AK; Hellerbrand C
    J Clin Invest; 2020 May; 130(5):2509-2526. PubMed ID: 31999643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma neuropeptide Y of children with neuroblastoma in relation to stage, age and prognosis, and tissue neuropeptide Y.
    Dötsch J; Christiansen H; Hänze J; Lampert F; Rascher W
    Regul Pept; 1998 Sep; 75-76():185-90. PubMed ID: 9802408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental Neuropeptide Y ( NPY) and NPY receptors expressions and serum NPY levels in preeclampsia.
    Klinjampa R; Sitticharoon C; Souvannavong-Vilivong X; Sripong C; Keadkraichaiwat I; Churintaraphan M; Chatree S; Lertbunnaphong T
    Exp Biol Med (Maywood); 2019 Apr; 244(5):380-388. PubMed ID: 30760028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects.
    Tilan JU; Lu C; Galli S; Izycka-Swieszewska E; Earnest JP; Shabbir A; Everhart LM; Wang S; Martin S; Horton M; Mahajan A; Christian D; O'Neill A; Wang H; Zhuang T; Czarnecka M; Johnson MD; Toretsky JA; Kitlinska J
    Oncotarget; 2013 Dec; 4(12):2487-501. PubMed ID: 24318733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y and its receptors in prostate cancer: associations with cancer invasiveness and perineural spread.
    Sigorski D; Wesołowski W; Gruszecka A; Gulczyński J; Zieliński P; Misiukiewicz S; Kitlińska J; Iżycka-Świeszewska E
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):5803-5822. PubMed ID: 36583743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.